| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An application study of low-dose computed tomography perfusion imaging for evaluation of the efficacy of neoadjuvant chemotherapy for advanced gastric adenocarcinoma
|
Sun, Zongqiong
|
|
2017
|
21 |
3 |
p. 413-420
|
artikel
|
| 2 |
A phase II study of combination therapy with oral S-1 and cisplatin in elderly patients with advanced gastric cancer
|
Sasaki, Yusuke
|
|
2017
|
21 |
3 |
p. 439-445
|
artikel
|
| 3 |
Correction to: Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC‑06)
|
Kimura, Yutaka
|
|
2017
|
21 |
3 |
p. 428
|
artikel
|
| 4 |
Development and validation of a risk assessment tool for gastric cancer in a general Japanese population
|
Iida, Masahiro
|
|
2017
|
21 |
3 |
p. 383-390
|
artikel
|
| 5 |
Factors influencing health-related quality of life after gastrectomy for cancer
|
Brenkman, Hylke J. F.
|
|
2017
|
21 |
3 |
p. 524-532
|
artikel
|
| 6 |
Health-related quality of life after gastrectomy, esophagectomy, and combined esophagogastrectomy for gastroesophageal junction adenocarcinoma
|
Kauppila, Joonas H.
|
|
2017
|
21 |
3 |
p. 533-541
|
artikel
|
| 7 |
Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma
|
Martin, Andrew J.
|
|
2017
|
21 |
3 |
p. 473-480
|
artikel
|
| 8 |
High adherence to the Western, Prudent, and Mediterranean dietary patterns and risk of gastric adenocarcinoma: MCC-Spain study
|
Castelló, Adela
|
|
2017
|
21 |
3 |
p. 372-382
|
artikel
|
| 9 |
How to adjust endoscopic findings to histopathological findings of the stomach: a “histopathology-oriented” correspondence method helps to understand endoscopic findings
|
Fujita, Yasuko
|
|
2017
|
21 |
3 |
p. 573-577
|
artikel
|
| 10 |
In situ analysis of FGFR2 mRNA and comparison with FGFR2 gene copy number by dual-color in situ hybridization in a large cohort of gastric cancer patients
|
Kuboki, Yasutoshi
|
|
2017
|
21 |
3 |
p. 401-412
|
artikel
|
| 11 |
Irinotecan monotherapy as third-line or later treatment in advanced gastric cancer
|
Makiyama, Akitaka
|
|
2017
|
21 |
3 |
p. 464-472
|
artikel
|
| 12 |
Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative study
|
Hatta, Waku
|
|
2017
|
21 |
3 |
p. 481-489
|
artikel
|
| 13 |
Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer meeting expanded indication including undifferentiated-type tumors: a criteria-based analysis
|
Lee, Sunpyo
|
|
2017
|
21 |
3 |
p. 490-499
|
artikel
|
| 14 |
Multicenter phase II study of trastuzumab plus S-1 alone in elderly patients with HER2-positive advanced gastric cancer (JACCRO GC-06)
|
Kimura, Yutaka
|
|
2017
|
21 |
3 |
p. 421-427
|
artikel
|
| 15 |
Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment
|
Kim, Sun Young
|
|
2017
|
21 |
3 |
p. 453-463
|
artikel
|
| 16 |
Optimal minimally invasive surgical procedure for gastric submucosal tumors
|
Shoji, Yoshiaki
|
|
2017
|
21 |
3 |
p. 508-515
|
artikel
|
| 17 |
Pancreatic enzyme supplementation after gastrectomy for gastric cancer: a randomized controlled trial
|
Catarci, Marco
|
|
2017
|
21 |
3 |
p. 542-551
|
artikel
|
| 18 |
Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis
|
Sisic, Leila
|
|
2017
|
21 |
3 |
p. 552-568
|
artikel
|
| 19 |
Preservation of the celiac branch of the vagal nerve for pylorus-preserving gastrectomy: is it meaningful?
|
Furukawa, Haruna
|
|
2017
|
21 |
3 |
p. 516-523
|
artikel
|
| 20 |
Priority of lymph node dissection for proximal gastric cancer invading the greater curvature
|
Maezawa, Yukio
|
|
2017
|
21 |
3 |
p. 569-572
|
artikel
|
| 21 |
Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm
|
Sawaki, Akira
|
|
2017
|
21 |
3 |
p. 429-438
|
artikel
|
| 22 |
Short-term outcomes and nutritional status after laparoscopic subtotal gastrectomy with a very small remnant stomach for cStage I proximal gastric carcinoma
|
Furukawa, Haruna
|
|
2017
|
21 |
3 |
p. 500-507
|
artikel
|
| 23 |
The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trials
|
Zhao, Ting-Ting
|
|
2018
|
21 |
3 |
p. 361-371
|
artikel
|
| 24 |
Time to initiation or duration of S-1 adjuvant chemotherapy; which really impacts on survival in stage II and III gastric cancer?
|
Fujitani, Kazumasa
|
|
2017
|
21 |
3 |
p. 446-452
|
artikel
|
| 25 |
Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis
|
He, Xingkang
|
|
2017
|
21 |
3 |
p. 391-400
|
artikel
|
Tijdschrift beschrijving